Full Name
Hausenloy D.
Derek J. Hausenloy
Main Affiliation


Results 1-20 of 50 (Search time: 0.021 seconds).

Issue DateTitleAuthor(s)
12014A retrospective analysis of myocardial preservation techniques during coronary artery bypass graft surgery: are we protecting the heart?Candilio, L; Malik, A; Ariti, C; Khan, S.A; Barnard, M; Di Salvo, C; Lawrence, D.R; Hayward, M.P; Yap, J.A; Sheikh, A.M; McGregor, C.G; Kolvekar, S.K; Hausenloy, D.J ; Yellon, D.M; Roberts, N
22017Age and surgical complexity impact on renoprotection by remote ischemic preconditioning during adult cardiac surgery: A meta analysisZhou, C; Bulluck, H; Fang, N; Li, L; Hausenloy, D.J 
32017Assessing the effects of mitofusin 2 deficiency in the adult heart using 3D electron tomographyKalkhoran, S.B; Hall, A.R; White, I.J; Cooper, J; Fan, Q ; Ong, S.-B ; Hernández-Reséndiz, S ; Cabrera-Fuentes, H ; Chinda, K; Chakraborty, B ; Dorn, G.W; Yellon, D.M; Hausenloy, D.J 
42016Automated Extracellular Volume Fraction Mapping Provides Insights Into the Pathophysiology of Left Ventricular Remodeling Post-Reperfused ST-Elevation Myocardial InfarctionBulluck, H; Rosmini, S; Abdel-Gadir, A; White, S.K; Bhuva, A.N; Treibel, T.A; Fontana, M; Gonzalez-Lopez, E; Reant, P; Ramlall, M; Hamarneh, A; Sirker, A; Herrey, A.S; Manisty, C; Yellon, D.M; Kellman, P; Moon, J.C; Hausenloy, D.J 
52020Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularizationSim, H.W.; Zheng, H.; Richards, A. Mark; Chen, R.W.; Sahlen, A.; Yeo, K.-K.; Tan, J.W.; Chua, T.; Tan, H.C. ; Yeo, T.C. ; Ho, H.H.; Liew, B.-W.; Foo, L.L.; Lee, C.-H. ; Hausenloy, D.J. ; Chan, M.Y. 
62011Cardiovascular magnetic resonance in cardiac sarcoidosis with MR conditional pacemaker in situQuarta G.; Holdright D.R.; Plant G.T.; Harkness A.; Hausenloy D. ; Hyare H.; Moon J.C.
72016Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioningPickard, J.M.J; Davidson, S.M; Hausenloy, D.J ; Yellon, D.M
82016Contrast-induced nephropathy following angiography and cardiac interventionsRear, R; Bell, R.M; Hausenloy, D.J 
92017Defining left ventricular remodeling following acute ST-segment elevation myocardial infarction using cardiovascular magnetic resonanceBulluck, H; Go, Y.Y; Crimi, G; Ludman, A.J; Rosmini, S; Abdel-Gadir, A; Bhuva, A.N; Treibel, T.A; Fontana, M; Pica, S; Raineri, C; Sirker, A; Herrey, A.S; Manisty, C; Groves, A; Moon, J.C; Hausenloy, D.J 
1021-Apr-2020Diabetic cardiomyopathy and ischemic heart disease: Prevention and therapy by exercise and conditioningCrisafulli, A.; Pagliaro, P.; Roberto, S.; Cugusi, L.; Mercuro, G.; Lazou, A.; Beauloye, C.; Bertrand, L.; Hausenloy, D.J. ; Aragno, M.; Penna, C.
112017Diagnostic performance of T1 and T2 mapping to detect intramyocardial hemorrhage in reperfused ST-segment elevation myocardial infarction (STEMI) patientsBulluck, H; Rosmini, S; Abdel-Gadir, A; Bhuva, A.N; Treibel, T.A; Fontana, M; Gonzalez-Lopez, E; Ramlall, M; Hamarneh, A; Sirker, A; Herrey, A.S; Manisty, C; Yellon, D.M; Moon, J.C; Hausenloy, D.J 
122013Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent mannerHausenloy D.J. ; Whittington H.J.; Wynne A.M.; Begum S.S.; Theodorou L.; Riksen N.; Mocanu M.M.; Yellon D.M.
132014DJ-1 protects against cell death following acute cardiac ischemiareperfusion injuryDongworth, R.K; Mukherjee, U.A; Hall, A.R; Astin, R; Ong, S.-B ; Yao, Z; Dyson, A; Szabadkai, G; Davidson, S.M; Yellon, D.M; Hausenloy, D.J 
142020Editorial: New Advances in RNA TargetingIlinskaya, O.; Hausenloy, D.J. ; Cabrera-Fuentes, H.A.; Zenkova, M.
152016Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study - A Single-Center, Blinded, Randomized Controlled TrialChung, R; Maulik, A; Hamarneh, A; Hochhauser, D; Hausenloy, D.J ; Walker, J.M; Yellon, D.M
162017Full left ventricular coverage is essential for the accurate quantification of the area-at-risk by T1 and T2 mappingBulluck, H; Bryant, J.A; Lim, M.X ; Tan, X.W; Ramlall, M; Francis, R; Kotecha, T; Cabrera-Fuentes, H.A ; Knight, D.S; Fontana, M; Moon, J.C; Hausenloy, D.J 
172016Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarctionHall, A.R; Burke, N; Dongworth, R.K; Kalkhoran, S.B; Dyson, A; Vicencio, J.M; Dorn, G.W; Yellon, D.M; Hausenloy, D.J 
182014HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition poreOng, S.-G; Lee, W.H; Theodorou, L; Kodo, K; Lim, S.Y; Shukla, D.H; Briston, T; Kiriakidis, S; Ashcroft, M; Davidson, S.M; Maxwell, P.H; Yellon, D.M; Hausenloy, D.J 
192016Impact of microvascular obstruction on semiautomated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonanceBulluck H.; Rosmini S.; Abdel-Gadir A.; Bhuva A.N.; Treibel T.A.; Fontana M.; Weinmann S.; Sirker A.; Herrey A.S.; Manisty C.; Moon J.C.; Hausenloy D.J. 
202018Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysisBulluck, H; Chan, M.H.H; Paradies, V; Yellon, R.L; Ho, H.H; Chan, M.Y ; Chin, C.W.L; Tan, J.W ; Hausenloy, D.J